Burgstahler David F
SEC-identified person · CIK 1374179 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Organogenesis Holdings Inc. ORGO | Director · President & CEO | filed 2016 - 2024 |
| Omniab, Inc. OABI | Director · President, CEO | filed 2021 - 2024 |
| RVL Pharmaceuticals plc RVLP | Director | filed 2018 - 2023 |
| Wideopenwest, Inc. WOW | Director | filed 2017 - 2019 |
| Lantheus Holdings, Inc. LNTH | Director | filed 2015 - 2017 |
| Syneos Health, Inc. SYNH | Director | filed 2014 - 2017 |
| Angiodynamics INC ANGO | Director | filed 2012 - 2017 |
| Warner Chilcott plc WCRX | Director | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.